Since ESR1, ESR2 and PGR impact the fuction of estrogen and progesterone, we hypothesized that the presence of functional polymorphisms in these genes would be associated with MS-AEs among postmenopausal breast cancer survivors on AI therapy. The gene discussed is ESR1; the disease is breast cancer.